Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pharmacotherapy augmentation strategies in treatment‐resistant anxiety disorders

Información

DOI:
https://doi.org/10.1002/14651858.CD005473.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2006see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Jonathan C Ipser

    Correspondencia a: MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, Tygerberg, South Africa

    [email protected]

  • Paul Carey

    Psychiatry, University of Stellenbosch, Tygerberg, South Africa

  • Yumna Dhansay

    MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, Tygerberg, South Africa

  • Nuraan Fakier

    Psychiatry, University of Stellenbosch, Tygerberg, South Africa

  • Soraya Seedat

    MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, Tygerberg, South Africa

  • Dan J Stein

    Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa

Contributions of authors

Jonathan Ipser was responsible for responding to editorial feedback, for writing the methods and results section of the review and for capturing and analysing the data. Nuraan Fakier assisted in double‐checking the trial data captured. Yumna Dhansay completed the background section of the review. Paul Carey and Soraya Seedat provided comprehensive feedback on the review. Dan Stein co‐ordinated and provided feedback on the review. Nuraan Fakier assisted in trial retrieval/selection and in double‐data entry.

Sources of support

Internal sources

  • MRC Unit on Anxiety Disorders, South Africa.

  • University of Cape Town, Cape Town, South Africa.

External sources

  • MRC Research Unit on Anxiety and Stress Disorders, South Africa.

Declarations of interest

The MRC Unit on Anxiety Disorders has been supported by each of the pharmaceutical companies with an interest in psychiatry in South Africa.

Potential conflicts of interest for individual reviewers

Jonathan Ipser has no known conflicts of interest outside of his affiliation by the MRC Unit on Anxiety Disorders.

Paul Carey has received research grants/honoria from Astra Zeneca, Glaxo‐Smithkline, Lundbeck, and Sanofi‐Aventis

Yumna Dhansay has no known conflicts of interest outside of her affiliation with the MRC Unit on Anxiety Disorders.

Soraya Seedat has received support from several companies (including GlaxoSmithKline, Eli‐Lilly, Pfizer, Cephalon, AstraZeneca, Lundbeck) and has participated in several clinical trials.

Nuraan Fakier has no known conflicts of interest outside of her affiliation with the MRC Unit on Anxiety Disorders.

Dan Stein has received research grants and/or consultancy honoraria from Astrazeneca, Eli‐Lilly, GlaxoSmithKline, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, and Wyeth. He has participated in a number of ongoing trials, and has presented data from some of these trials on behalf of the sponsoring companies.

Acknowledgements

The authors are supported by the MRC Research Unit on Anxiety and Stress Disorders (Cape Town, South Africa). We wish to thank Eric Hollander (and Nicolo Rossi), Mendel Fux and colleagues, Stefano Pallanti, and Stefano Erzegovesi for responding to requests for additional data for the review. We would also like to express our gratitude to Luzaan van Wyk and Simon Hagger of AstraZeneca and Mark Pollack for letting us have access to unpublished trials, and the CCDAN editorial base for their assistance. Joy Oliver of the South African Cochrane Centre helped retrieve trial reports for inclusion in the review.

Version history

Published

Title

Stage

Authors

Version

2006 Oct 18

Pharmacotherapy augmentation strategies in treatment‐resistant anxiety disorders

Review

Jonathan C Ipser, Paul Carey, Yumna Dhansay, Nuraan Fakier, Soraya Seedat, Dan J Stein

https://doi.org/10.1002/14651858.CD005473.pub2

2005 Jul 20

Pharmacotherapy augmentation strategies in treatment‐resistant anxiety disorders

Protocol

Yumna Dhansay, Jonathan C Ipser, Dan J Stein

https://doi.org/10.1002/14651858.CD005473